|
1.
|
Walter P and Ron D: The unfolded protein
response: from stress pathway to homeostatic regulation. Science.
334:1081–1086. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Schröder M and Kaufman RJ: The mammalian
unfolded protein response. Annu Rev Biochem. 74:739–789. 2005.
|
|
3.
|
Ron D and Walter P: Signal integration in
the endoplasmic reticulum unfolded protein response. Nat Rev Mol
Cell Biol. 8:519–529. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Ellgaard L and Helenius A: Quality control
in the endoplasmic reticulum. Nat Rev Mol Cell Biol. 4:181–191.
2003. View
Article : Google Scholar
|
|
5.
|
Ron D: Translational control in the
endoplasmic reticulum stress response. J Clin Invest.
110:1383–1388. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Tassone P, Tagliaferri P, Fulciniti MT, Di
Martino MT and Venuta S: Novel therapeutic approaches based on the
targeting of microenvironment-derived survival pathways in human
cancer: experimental models and translational issues. Curr Pharm
Des. 13:487–496. 2007. View Article : Google Scholar
|
|
7.
|
Wilson TR, Johnston PG and Longley DB:
Anti-apoptotic mechanisms of drug resistance in cancer. Curr Cancer
Drug Targets. 9:307–319. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Reddy RK, Mao C, Baumeister P, Austin RC,
Kaufman RJ and Lee AS: Endoplasmic reticulum chaperone protein
GRP78 protects cells from apoptosis induced by topoisomerase
inhibitors: role of ATP binding site in suppression of caspase-7
activation. J Biol Chem. 278:20915–20924. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Amoroso MR, Matassa DS, Laudiero G, et al:
TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in
the endoplasmic reticulum and control cellular ubiquitination of
specific mitochondrial proteins. Cell Death Differ. 19:592–604.
2012. View Article : Google Scholar
|
|
10.
|
Takemoto K, Miyata S, Takamura H, Katayama
T and Tohyama M: Mitochondrial TRAP1 regulates the unfolded protein
response in the endoplasmic reticulum. Neurochem Int. 58:880–887.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Siegelin MD, Dohi T, Raskett CM, et al:
Exploiting the mitochondrial unfolded protein response for cancer
therapy in mice and human cells. J Clin Invest. 121:1349–1360.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kang BH, Plescia J, Dohi T, Rosa J, Doxsey
SJ and Altieri DC: Regulation of tumor cell mitochondrial
homeostasis by an organelle-specific Hsp90 chaperone network. Cell.
131:257–270. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Costantino E, Maddalena F, Calise S, et
al: TRAP1, a novel mitochondrial chaperone responsible for
multi-drug resistance and protection from apoptotis in human
colorectal carcinoma cells. Cancer Lett. 279:39–46. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Leav I, Plescia J, Goel HL, et al:
Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular
target in localized and metastatic prostate cancer. Am J Pathol.
176:393–340. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Fang W, Li X, Jiang Q, et al:
Transcriptional patterns, biomarkers and pathways characterizing
nasopharyngeal carcinoma of Southern China. J Transl Med. 6:322008.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Landriscina M, Maddalena F, Laudiero G and
Esposito F: Adaptation to oxidative stress, chemoresistance, and
cell survival. Antioxid Redox Signal. 11:2701–2716. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Landriscina M, Laudiero G, Maddalena F, et
al: Mitochondrial chaperone Trap1 and the calcium binding protein
Sorcin interact and protect cells against apoptosis induced by
anti-blastic agents. Cancer Res. 70:6577–6586. 2010. View Article : Google Scholar
|
|
18.
|
Maddalena F, Sisinni L, Lettini G, et al:
Resistance to paclitxel in breast carcinoma cells requires a
quality control of mitochondrial antiapoptotic proteins by TRAP1.
Mol Oncol. 7:895–906. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Hande KR: Clinical applications of
anticancer drugs targeted to topoisomerase II. Biochim Biophys
Acta. 1400:173–184. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Minotti G, Menna P, Salvatorelli E, Cairo
G and Gianni L: Anthracyclines: molecular advances and
pharmacologic developments in antitumor activity and
cardiotoxicity. Pharmacol Rev. 56:185–229. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Jiang CC, Mao ZG, Avery-Kiejda KA, Wade M,
Hersey P and Zhang XD: Glucose-regulated protein 78 antagonizes
cisplatin and adriamycin in human melanoma cells. Carcinogenesis.
30:197–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Chae YC, Caino MC, Lisanti S, et al:
Control of tumor bioenergetics and survival stress signaling by
mitochondrial HSP90s. Cancer Cell. 22:331–344. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Scriven P, Coulson S, Haines R,
Balasubramanian S, Cross S and Wyld L: Activation and clinical
significance of the unfolded protein response in breast cancer. Br
J Cancer. 101:1692–1698. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Tan SS, Ahmad I, Bennett HL, et al: GRP78
up-regulation is associated with androgen receptor status,
Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer.
J Pathol. 223:81–87. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Khasraw M, Bell R and Dang C: Epirubicin:
is it like doxorubicin in breast cancer? A clinical review Breast.
21:142–149. 2012.PubMed/NCBI
|
|
26.
|
Barone C, Landriscina M, Quirino M, et al:
Schedule-dependent activity of 5-fluorouracil and irinotecan
combination in the treatment of human colorectal cancer: in vitro
evidence and a phase I dose-escalating clinical trial. Br J Cancer.
96:21–28. 2007. View Article : Google Scholar
|
|
27.
|
Landriscina M, Fabiano A, Altamura S, et
al: Reverse transcriptase inhibitors down-regulate cell
proliferation in vitro and in vivo and restore thyrotropin
signaling and iodine uptake in human thyroid anaplastic carcinoma.
J Clin Endocrinol Metab. 90:5663–5671. 2005. View Article : Google Scholar
|
|
28.
|
Maddalena F, Laudiero G, Piscazzi A, et
al: Sorcin induces a drug-resistant phenotype in human colorectal
cancer by modulating Ca(2+) homeostasis. Cancer Res. 71:7659–7669.
2011.PubMed/NCBI
|
|
29.
|
Feng R, Zhai WL, Yang HY, Jin H and Zhang
QX: Induction of ER stress protects gastric cancer cells against
apoptosis induced by cisplatin and doxorubicin through activation
of p38 MAPK. Biochem Biophys Res Commun. 406:299–304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Mhaidat NM, Thorne R, Zhang XD and Hersey
P: Involvement of endoplasmic reticulum stress in Docetaxel-induced
JNK-dependent apoptosis of human melanoma. Apoptosis. 13:1505–1512.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Harding HP, Zhang Y and Ron D: Protein
translation and folding are coupled by an
endoplasmic-reticulum-resident kinase. Nature. 397:271–274. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Harding HP, Novoa I, Zhang Y, et al:
Regulated translation initiation controls stress-induced gene
expression in mammalian cells. Mol Cell. 6:1099–1108. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Farmaki E, Mkrtchian S, Papazian I,
Papavassiliou AG and Kiaris H: ERp29 regulates response to
doxorubicin by a PERK-mediated mechanism. Biochim Biophys Acta.
1813:1165–1171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Matassa DS, Amoroso MR, Crudele V, et al:
Translational control in the stress adaptive response of cancer
cells: a novel role for the heat shock protein TRAP1. Cell Death
Dis. 4:e851 View Article : Google Scholar : 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Wang J, Yin Y, Hua H, et al: Blockade of
GRP78 sensitizes breast cancer cells to microtubules-interfering
agents that induce the unfolded protein response. J Cell Mol Med.
13:3888–3897. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Kang BH: TRAP1 regulation of mitochondrial
life or death decision in cancer cells and mitochondria-targeted
TRAP1 inhibitors. BMB Rep. 45:1–6. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Neckers L, Kern A and Tsutsumi S: Hsp90
inhibitors disrupt mitochondrial homeostasis in cancer cells. Chem
Biol. 14:1204–1206. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Xu W, Mimnaugh E, Rosser MF, et al:
Sensitivity of mature Erbb2 to geldanamycin is conferred by its
kinase domain and is mediated by the chaperone protein Hsp90. J
Biol Chem. 276:3702–3708. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Basso AD, Solit DB, Munster PN and Rosen
N: Ansamycin antibiotics inhibit Akt activation and cyclin D
expression in breast cancer cells that overexpress HER2. Oncogene.
21:1159–1166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Brouckaert O, Wildiers H, Floris G and
Neven P: Update on triple-negative breast cancer: prognosis and
management strategies. Int J Womens Health. 4:511–520.
2012.PubMed/NCBI
|
